• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Maitake mushrooms (Grifola frondosa) enhances antibody production in response to influenza vaccination in healthy adult volunteers concurrent with all

Emily

Editor, Senior Moderator
https://ffhdj.com/index.php/ffhd/article/view/363
Functional Foods in Health and Disease (FFHD) journal
Vol 7, No 7 (2017) > Nishihira [h=3]Maitake mushrooms (Grifola frondosa) enhances antibody production in response to influenza vaccination in healthy adult volunteers concurrent with alleviation of common cold symptoms[/h] un Nishihira, Mayumi Sato, Aiko Tanaka, Masatoshi Okamatsu, Tomonori Azuma, Naonobu Tsutsumi, Shozo Yoneyama [h=4]Abstract[/h] Background: The prevention of influenza virus infection is a critical public health challenge.Thus new, safe, and effective strategies are needed to reduce the risk of infection. Maitake mushrooms (Grifola frondosa) are popular in Asia for their flavor and immune-stimulating properties. In this study, we examined whether the dietary consumption of Maitake was effective in boosting the potency of influenza virus vaccination.
Methods: We set up a double-blind, placebo-controlled clinical trial (n=50 subjects for Maitake consumption; n=50 for placebo) and analyzed hemagglutination inhibition (HI) antibody titers in response to trivalent influenza vaccine (type A H1N1, H3N2, and type B BX-51B) for a 12-week period of daily Maitake intake (6.825g), beginning 4 weeks before and continuing 8 weeks after vaccination. We also evaluated the efficacy of Maitake for suppression of common cold symptoms by questionnaire.
Results: We found that continuous Maitake intake raised HI titers against influenza type A virus H1N1 and type B virus, and significantly increased the seroconversion rate for older adults (>60 years of age). Additionally, severe cold symptoms including rhinorrhea and headache were significantly improved by Maitake intake.
Conclusion: In this clinical trial, we demonstrated that Maitake intake enhanced antibody production in response to influenza vaccination while simultaneously suppressing multiple common cold symptoms. The current results suggest that Maitake may activate both innate and adaptive immune responses for the prevention of virus infection. In conclusion, we expect that Maitake intake potentiates host defense systems and has a protective effect against influenza virus and other pathogenic viruses and bacteria.
Keywords: clinical trial, Grifola frondosa, influenza, Maitake, vaccine
 
Back
Top Bottom